Risk factors for prolonged carriage of vancomycin-resistant enterococcus faecium among patients in intensive care units: A case-control study

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1831-1838

  Yoon, Young Kyung ^a,b   Lee, Seung Eun ^a   Lee, Juneyoung ^c   Kim, Hyun Jeong ^a   Kim, Jeong Yeon ^a   Park, Dae Won ^a,b   Sohn, Jang Wook ^a,b   Kim, Min Ja ^a,b  

^a Korea University Ansan Hospital   (South Korea)

^b Korea University   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

ICUs; Infection control; Time series analysis

Indexed keywords

AMINOGLYCOSIDE; ANTACID AGENT; CARBAPENEM; CEPHALOSPORIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTERIAL COLONIZATION; BALLOON CATHETER; BRONCHOSCOPY; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE SURVEILLANCE; DRUG USE; ENDOTRACHEAL INTUBATION; ENTEROCOCCAL INFECTION; FECES CULTURE; FEMALE; GASTRODUODENAL ULCER; GASTROSCOPY; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER DYSFUNCTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOGASTRIC TUBE; NEOPLASM; NEUROLOGIC DISEASE; NEUTROPENIA; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; TOTAL PARENTERAL NUTRITION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARRIER STATE; CASE-CONTROL STUDIES; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; KOREA; MALE; MIDDLE AGED; MODELS, STATISTICAL; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 79960447644     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr204     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention: nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993; 42: 597-9.
2. Montecalvo MA, Horowitz H, Gedris C et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-7.
3. Song X, Srinivasan A, Plaut D et al. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol 2003; 24: 251-6.
4. Pelz RK, Lipsett PA, Swoboda SM et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 2002; 28: 692-7.
5. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72: 195-8.
6. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-7.
7. Byers KE, Anglim AM, Anneski CJ et al. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002; 23: 207-11.
8. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995; 23: 87-94.
9. Patel R, Allen SL, Manahan JM et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7: 27-31.
10. Wong MT, Kauffman CA, Standiford HC et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33: 1476-82.
11. Rand KH, Houck H. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 2004; 53: 530-2.
12. Boyce JM, Opal SM, Chow JW et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-53.
13. Henning KJ, Delencastre H, Eagan J et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996; 15: 848-54.
14. Baden LR, Thiemke W, Skolnik A et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". Clin Infect Dis 2001; 33: 1654-60.
15. Donskey CJ, Hoyen CK, Das SM et al. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002; 23: 436-40.
16. Muto CA, Jernigan JA, Ostrowsky BE et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-86.
17. Swenson JM, Clark NC, Ferraro MJ et al. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol 1994; 32: 1700-4.
18. Bonten MJ, Slaughter S, Ambergen AWet al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158: 1127-32.
19. Novicki TJ, Schapiro JM, Ulness BK et al. Convenient selective differential broth for isolation of vancomycin-resistant Enterococcus from fecal material. J Clin Microbiol 2004; 42: 1637-40.
20. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Seventh Edition: Approved Standard M7-A7. CLSI, Wayne, PA, USA, 2006.
21. Gallant AR, Goebel JJ. Nonlinear regression with autoregressive errors. J Am Stat Assoc 1976; 71: 961-7.
22. Drees M, Snydman DR, Schmid CH et al. Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 2008; 29: 709-15.
23. Green M, Barbadora K, Michaels M. Recovery of vancomycin-resistant gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 1991; 29: 2503-6.
24. Sakka V, Tsiodras S, Galani L et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008; 14: 14-21.
25. Wibbenmeyer L, Williams I, Ward M et al. Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit. J Burn Care Res 2010; 31: 269-79.
26. Morris JG Jr, Shay DK, Hebden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-9.
27. Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-33.
28. Korten V, Murray BE. Impact of the fluoroquinolones on gastrointestinal flora. Drugs 1993; 45: 125-33.
29. Brismar B, Edlund C, Malmborg AS et al. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1990; 34: 481-3.
30. Leavis HL, Willems RJ, Top J et al. High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. J Clin Microbiol 2006; 44: 1059-64.
31. Willems RJ, Top J, van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-8.
32. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925-32.
33. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002; 46: 1619-28.
34. Edlund C, Barkholt L, Olsson-Liljequist B et al. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997; 25: 729-32.
35. Currie BP, Lemos-Filho L. Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother 2004; 48: 4427-9.
36. de Bruin MA, Riley LW. Does vancomycin prescribing intervention affect vancomycin-resistant Enterococcus infection and colonization in hospitals? A systematic review. BMC Infect Dis 2007; 7: 24.